High-Yield LeukoCore™ Myasthenia Gravis Leukopak for Immunology Research

LeukoCore™ Myasthenia Gravis Leukopak biospecimens are collected from donors clinically diagnosed with Myasthenia Gravis (MG) through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for studying autoantibody production, T-cell regulation, immune dysfunction, and immunotherapy development.

Product Features

• Research Use Only (RUO) human leukopaks
• Clinically confirmed MG donors
• High cell yield for large-scale studies
• Processed and shipped within 24 hours of collection
• Fresh or cryopreserved options available
• IRB-approved and ethically sourced
• Infectious disease testing
• HLA-A typing
• Screen donors with LeukoLot™

Donor Metadata

• Verified MG diagnosis from healthcare providers
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported medication history and allergies
• Relevant clinical data

Applications

• Immune cell characterization in MG
• Therapeutic development and screening
• Cell-based assays and cytokine profiling
• Multi-omics studies including single-cell sequencing

Compliance and Quality Assurance

• Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
• HIPAA-compliant handling of donor information
• Rigorous donor screening and documentation

Ordering & Customization

Myasthenia Gravis Leukopak is available fresh or cryopreserved. For international shipping or regulatory documentation, please contact to confirm regional compliance and shipping availability.